Nova Eye Medical (Nova Eye Medical) Short Interest

View and export this data going back to 2005. Start your Free Trial

What is Nova Eye Medical Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Nova Eye Medical's Short Interest

For the Medical Devices subindustry, Nova Eye Medical's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Eye Medical's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nova Eye Medical's Short Interest distribution charts can be found below:

* The bar in red indicates where Nova Eye Medical's Short Interest falls into.

Nova Eye Medical (Nova Eye Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nova Eye Medical Ltd (OTCPK:ELXMF) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

EYE:Australia

Address

107 Rundle Street, Kent Town, Adelaide, SA, AUS, 5067

Website

https://www.nova-eye.com

Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.

Nova Eye Medical (Nova Eye Medical) Headlines

From GuruFocus

Nova Eye Medical Announces U.S. Market Clearance of the iTrack� Advance Canaloplasty Device

By Business Wire Business Wire • 04-12-2023

ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer

By PRNewswire PRNewswire • 07-30-2018